查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1888673

急性呼吸道疾病诊断市场规模、份额和趋势分析报告：按检测方法、病原体、最终用途、地区和细分市场预测（2025-2033 年）

Acute Respiratory Disease Diagnostics Market Size, Share & Trends Analysis Report By Test, By Pathogen, By End-use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

急性呼吸系统疾病诊断市场摘要

2024年全球急性呼吸系统疾病诊断市场规模估计为54.9亿美元，预计2033年将达到107.1亿美元。

预计从 2025 年到 2033 年，该市场将以 7.01% 的复合年增长率成长。推动市场成长的关键因素包括呼吸系统疾病负担加重、诊断技术的进步以及对早期检测和分散式检查需求的不断增长。

根据健康指标与评估研究所 (IHME) 2023 年 4 月发布的报告，慢性呼吸道疾病 (CRD) 是全球第三大死因。此外，人口老化、医疗基础设施扩建、发展中市场投资增加、政府主导的各项措施、公共卫生项目以及资金投入等人口结构变化正在推动市场成长。随着全球老年人口比例的不断上升，呼吸系统疾病病例数量也在增加，因为老化通常伴随着肺功能下降和免疫系统减弱。这种人口结构变化显着增加了慢性及急性感染疾病（包括肺炎、慢性阻塞性肺病(COPD) 和流感等合併症）的风险。因此，人口老化推动了对快速、精准诊断工具的需求，旨在实现早期发现、及时介入并改善临床疗效。

同时，新兴经济体的医疗卫生基础设施正在迅速扩张，为采用新的诊断技术奠定了坚实的基础。亚太、拉丁美洲和中东各国正大力投资医疗卫生现代化、检查室自动化和创新医疗设备的研发。各国政府和私人医疗机构正透过公私合营，加强诊断能力，建立专门的呼吸系统检测中心，并引进就地检验。这些措施将改善诊断服务的可近性，加快检测速度，并加强都市区地区的疾病防治。

此外，政府计画和国际公共卫生倡议在支持全球诊断生态系统方面发挥着至关重要的作用。世界卫生组织、全球基金和各国卫生署为加强呼吸系统疾病监测、资助研究以及确保公平获取关键诊断材料所做的努力表明，全球诊断界正在携手合作，以增强诊断能力并改善公众健康。不断变化的报销环境、公众意识宣传活动、全球创新战略资金以及合作研究正在重塑全球分子和数位诊断的格局。这些努力旨在透过早期、准确和可近的诊断来减轻急性呼吸系统疾病的负担，建立一个完善的生态系统，并最终改善公众健康。

目录

第一章 急性呼吸系统疾病诊断市场：调查方法与范围

2. 急性呼吸系统疾病诊断市场：执行摘要

  • 市场概览
  • 检查概述
  • 病原体概述
  • 最终用途概述
  • 竞争格局概述

3. 急性呼吸系统疾病诊断市场的变数、趋势和范围

  • 市场区隔和范围
  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
  • 市场驱动因素分析
    • 呼吸系统疾病负担日益加重
    • 诊断技术的进步
    • 对早期检测和分散式检查的需求日益增长
  • 市场限制因素分析
    • 先进诊断技术高成本
    • 意识薄弱且检测不足
    • 基础设施和熟练劳动力方面的限制
  • 波特五力分析
  • PESTLE分析
  • 管道分析

第四章 急性呼吸系统疾病诊断市场：依检测方法分類的估算与趋势分析

  • 急性呼吸道疾病诊断市场：按检测方法分類的趋势分析
  • 分子诊断
    • PCR
    • INAAT
  • 基于抗原的快速检测
  • 血清学检测（IgM/IgG）
  • 症候群特异性呼吸道检测
  • 其他新兴技术（基于 CRISPR 的技术、奈米孔定序、人工智慧驱动的成像）

第五章 急性呼吸道疾病诊断市场：依病原体分類的估算与趋势分析

  • 急性呼吸道疾病诊断市场：依病原体分類的差异分析
  • 病毒感染疾病
    • 甲型和乙型流感
    • 呼吸道融合细胞病毒（RSV）
    • SARS-CoV-2
    • 其他的
  • 细菌感染疾病
    • 肺炎球菌
    • 流感细菌
    • 肺炎霉浆菌
    • 百日咳桿菌
  • 其他的

第六章：急性呼吸系统疾病诊断市场：依最终用途分類的估算与趋势分析

  • 急性呼吸系统疾病诊断市场：依最终用途分類的差异分析
  • 医院和诊所
  • 诊断与参考检查室
  • 居家检测
  • 其他（公共卫生、监测实验室）

7. 急性呼吸系统疾病诊断市场：区域业务分析

  • 区域市场概览
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东和非洲

第八章 竞争情势

  • 公司分类
  • 策略规划
    • 新产品发布
    • 合伙
    • 获得
    • 合资
    • 资金筹措
  • 主要企业市占率分析（2024 年）
  • 公司热力图分析
  • 公司简介
    • F. Hoffmann La-Roche
    • Abbott Laboratories
    • Quidel Corporation
    • Becton, Dickinson and Company（BD）
    • Thermo Fisher Scientific, Inc.
    • Siemens Healthineers
    • Bio-Rad Laboratories
    • Luminex Corporation
    • BioMerieux
    • Meridian Bioscience
    • Fujirebio Diagnostics
    • Cepheid
    • Lumos Diagnostics
Product Code: GVR-4-68040-812-9

Acute Respiratory Disease Diagnostics Market Summary

The global acute respiratory disease diagnostics market size was estimated at USD 5.49 billion in 2024 and is projected to reach USD 10.71 billion by 2033, growing at a CAGR of 7.01% from 2025 to 2033. Some of the major factors driving the market are rising disease burden of respiratory conditions, advancements in diagnostic technologies, and increasing demand for early detection & decentralized testing.

According to the Institute for Health Metrics and Evaluation (IHME) in April 2023, chronic respiratory diseases (CRDs) are the third leading cause of death globally. Furthermore, the market growth is driven by the ageing demographic shift, increased healthcare infrastructure & investment in developing markets, government initiatives, public health programs & funding. The rise in the proportion of older people globally has led to an increase in cases of respiratory disorders, as older age is often associated with decreased lung capacity and decreased immune functioning. This demographic shift introduces significant risk for the development of chronic and acute infections with co-morbidities, including pneumonia, chronic obstructive pulmonary disease (COPD), and influenza. As a result, there is an increasing demand for rapid and accurate diagnostic tools for early detection, timely intervention, and improved clinical outcomes among the aging demographic.

Simultaneously, the healthcare infrastructure in emerging economies is rapidly expanding, providing a solid base for the adoption of new diagnostic techniques. Countries in the Asia-Pacific, Latin America, and Middle East regions are seeing significant investments in the modernization of healthcare, laboratory automation, and the development of innovative devices. Governments and private healthcare providers are collaborating to enhance diagnostic capacity through public-private partnerships, the establishment of specialized respiratory testing centers, and the implementation of point-of-care testing. These efforts will lead to increased access to diagnostic services, shorter turnaround times, and enhanced disease management in both urban and rural areas.

In addition, government programs and international public health initiatives play a crucial role in supporting the global diagnostic ecosystem. Existing efforts by the WHO, the Global Fund, and the Ministries of Health of various countries to enhance surveillance of respiratory diseases, fund research, and provide equitable access to critical diagnostic supplies indicate that the global diagnostic community is working collaboratively to strengthen diagnostic capabilities worldwide and improve public health. Changes in reimbursement environments, public awareness campaigns, global strategic funding for innovations, and collaborative research efforts are reshaping global adherence to molecular and digital diagnostics. Overall, these aims aim to provide an ecosystem and ultimately improve public health by reducing the burden of acute respiratory disease through early, accurate, and accessible diagnostics.

Global Acute Respiratory Disease Diagnostics Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global acute respiratory disease diagnostics market based on test, pathogen, end-use, and region:

  • Test Outlook (Revenue, USD Million, 2021 - 2033)
  • Molecular Diagnostics
    • PCR
    • INAAT
  • Antigen-based Rapid Tests
  • Serological Tests (IgM/IgG)
  • Syndromic Respiratory Panels
  • Other Emerging Technologies (CRISPR-based, Nanopore Sequencing, AI-driven Imaging)
  • Pathogen Outlook (Revenue, USD Million, 2021 - 2033)
  • Viral Infections
    • Influenza A & B
    • Respiratory Syncytial Virus (RSV)
    • SARS-CoV-2
    • Others
  • Bacterial Infections
    • Streptococcus pneumoniae
    • Haemophilus influenzae
    • Mycoplasma pneumoniae
    • Bordetella pertussis
  • Others
  • End-use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals & Clinics
  • Diagnostic and Reference Labs
  • Home Testing
  • Others (Public health, surveillance labs)
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Acute Respiratory Disease Diagnostics Market: Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definitions
      • 1.1.1.1. Test Method
      • 1.1.1.2. Pathogen Segment
      • 1.1.1.3. End Use Segment
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Objectives
    • 1.4.1. Objective - 1
    • 1.4.2. Objective - 2
    • 1.4.3. Objective - 3
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information or Data Analysis
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
  • 1.10. List of Secondary Sources
  • 1.11. List of Abbreviations

Chapter 2. Acute Respiratory Disease Diagnostics Market: Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Test Snapshot
  • 2.3. Pathogen Snapshot
  • 2.4. End Use Snapshot
  • 2.5. Competitive Landscape Snapshot

Chapter 3. Acute Respiratory Disease Diagnostics Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Dynamics
  • 3.4. Market Drivers Analysis
    • 3.4.1. Rising disease burden of respiratory conditions
    • 3.4.2. Advancements in diagnostic technologies
    • 3.4.3. Increasing demand for early detection and decentralised testing
  • 3.5. Market Restraint Analysis
    • 3.5.1. High cost of advanced diagnostics
    • 3.5.2. Limited awareness and under-screening
    • 3.5.3. Infrastructure & skilled workforce constraints
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis
  • 3.8. Pipeline Analysis

Chapter 4. Acute Respiratory Disease Diagnostics Market: Test Estimates & Trend Analysis

  • 4.1. Acute Respiratory Disease Diagnostics Market: Test Movement Analysis
  • 4.2. Molecular Diagnostics
    • 4.2.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.2.2. PCR
      • 4.2.2.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.2.3. INAAT
      • 4.2.3.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.3. Antigen-based Rapid Tests
    • 4.3.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4. Serological Tests (IgM/IgG)
    • 4.4.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Syndromic Respiratory Panels
    • 4.5.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Other Emerging Technologies (CRISPR-based, Nanopore Sequencing, AI-driven Imaging)
    • 4.6.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Acute Respiratory Disease Diagnostics Market: Pathogen Estimates & Trend Analysis

  • 5.1. Acute Respiratory Disease Diagnostics Market: Pathogen Movement Analysis
  • 5.2. Viral Infections
    • 5.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.2.2. Influenza A & B
      • 5.2.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.2.3. Respiratory Syncytial Virus (RSV)
      • 5.2.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.2.4. SARS-CoV-2
      • 5.2.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.2.5. Others
      • 5.2.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.3. Bacterial Infections
    • 5.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.3.2. Streptococcus pneumoniae
      • 5.3.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.3.3. Haemophilus influenzae
      • 5.3.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.3.4. Mycoplasma pneumoniae
      • 5.3.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.3.5. Bordetella pertussis
      • 5.3.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4. Others
    • 5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Acute Respiratory Disease Diagnostics Market: End Use Estimates & Trend Analysis

  • 6.1. Acute Respiratory Disease Diagnostics Market: End Use Movement Analysis
  • 6.2. Hospitals & Clinics
    • 6.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.3. Diagnostic and Reference Labs
    • 6.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4. Home Testing
    • 6.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Others (Public health, surveillance labs)
    • 6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Acute Respiratory Disease Diagnostics Market: Regional Business Analysis

  • 7.1. Regional Market Snapshot
  • 7.2. North America
    • 7.2.1. North America Acute Respiratory Disease Diagnostics Market Estimates and Forecast, 2021 - 2033 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. U.S. Acute Respiratory Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 7.2.2.2. Key Country Dynamics
      • 7.2.2.3. Regulatory Framework
      • 7.2.2.4. Reimbursement Scenario
      • 7.2.2.5. Competitive Scenario
    • 7.2.3. Canada
      • 7.2.3.1. Canada Acute Respiratory Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 7.2.3.2. Key Country Dynamics
      • 7.2.3.3. Regulatory Framework
      • 7.2.3.4. Reimbursement Scenario
      • 7.2.3.5. Competitive Scenario
    • 7.2.4. Mexico
      • 7.2.4.1. Mexico Acute Respiratory Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 7.2.4.2. Key Country Dynamics
      • 7.2.4.3. Regulatory Framework
      • 7.2.4.4. Reimbursement Scenario
      • 7.2.4.5. Competitive Scenario
  • 7.3. Europe
    • 7.3.1. Europe Acute Respiratory Disease Diagnostics Market, 2021 - 2033 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. UK Acute Respiratory Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 7.3.2.2. Key Country Dynamics
      • 7.3.2.3. Regulatory Framework
      • 7.3.2.4. Reimbursement Scenario
      • 7.3.2.5. Competitive Scenario
    • 7.3.3. Germany
      • 7.3.3.1. Germany Acute Respiratory Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 7.3.3.2. Key Country Dynamics
      • 7.3.3.3. Regulatory Framework
      • 7.3.3.4. Reimbursement Scenario
      • 7.3.3.5. Competitive Scenario
    • 7.3.4. Spain
      • 7.3.4.1. Spain Acute Respiratory Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 7.3.4.2. Key Country Dynamics
      • 7.3.4.3. Regulatory Framework
      • 7.3.4.4. Reimbursement Scenario
      • 7.3.4.5. Competitive Scenario
    • 7.3.5. France
      • 7.3.5.1. France Acute Respiratory Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 7.3.5.2. Key Country Dynamics
      • 7.3.5.3. Regulatory Framework
      • 7.3.5.4. Reimbursement Scenario
      • 7.3.5.5. Competitive Scenario
    • 7.3.6. Italy
      • 7.3.6.1. Italy Acute Respiratory Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 7.3.6.2. Key Country Dynamics
      • 7.3.6.3. Regulatory Framework
      • 7.3.6.4. Reimbursement Scenario
      • 7.3.6.5. Competitive Scenario
    • 7.3.7. Denmark
      • 7.3.7.1. Denmark Acute Respiratory Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 7.3.7.2. Key Country Dynamics
      • 7.3.7.3. Regulatory Framework
      • 7.3.7.4. Reimbursement Scenario
      • 7.3.7.5. Competitive Scenario
    • 7.3.8. Sweden
      • 7.3.8.1. Sweden Acute Respiratory Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 7.3.8.2. Key Country Dynamics
      • 7.3.8.3. Regulatory Framework
      • 7.3.8.4. Reimbursement Scenario
      • 7.3.8.5. Competitive Scenario
    • 7.3.9. Norway
      • 7.3.9.1. Norway Acute Respiratory Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 7.3.9.2. Key Country Dynamics
      • 7.3.9.3. Regulatory Framework
      • 7.3.9.4. Reimbursement Scenario
      • 7.3.9.5. Competitive Scenario
  • 7.4. Asia Pacific
    • 7.4.1. Asia-Pacific Acute Respiratory Disease Diagnostics Market, 2021 - 2033 (USD Million)
    • 7.4.2. Japan
      • 7.4.2.1. Japan Acute Respiratory Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 7.4.2.2. Key Country Dynamics
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. Reimbursement Scenario
      • 7.4.2.5. Competitive Scenario
    • 7.4.3. China
      • 7.4.3.1. China Acute Respiratory Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 7.4.3.2. Key Country Dynamics
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. Reimbursement Scenario
      • 7.4.3.5. Competitive Scenario
    • 7.4.4. India
      • 7.4.4.1. India Acute Respiratory Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 7.4.4.2. Key Country Dynamics
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. Reimbursement Scenario
      • 7.4.4.5. Competitive Scenario
    • 7.4.5. South Korea
      • 7.4.5.1. South Korea Acute Respiratory Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 7.4.5.2. Key Country Dynamics
      • 7.4.5.3. Regulatory Framework
      • 7.4.5.4. Reimbursement Scenario
      • 7.4.5.5. Competitive Scenario
    • 7.4.6. Thailand
      • 7.4.6.1. Thailand Acute Respiratory Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 7.4.6.2. Key Country Dynamics
      • 7.4.6.3. Regulatory Framework
      • 7.4.6.4. Reimbursement Scenario
      • 7.4.6.5. Competitive Scenario
    • 7.4.7. Australia
      • 7.4.7.1. Australia Acute Respiratory Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 7.4.7.2. Key Country Dynamics
      • 7.4.7.3. Regulatory Framework
      • 7.4.7.4. Reimbursement Scenario
      • 7.4.7.5. Competitive Scenario
  • 7.5. Latin America
    • 7.5.1. Latin America Acute Respiratory Disease Diagnostics Market, 2021 - 2033 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Brazil Acute Respiratory Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 7.5.2.2. Key Country Dynamics
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Reimbursement Scenario
      • 7.5.2.5. Competitive Scenario
    • 7.5.3. Argentina
      • 7.5.3.1. Argentina Acute Respiratory Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 7.5.3.2. Key Country Dynamics
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Reimbursement Scenario
      • 7.5.3.5. Competitive Scenario
  • 7.6. MEA
    • 7.6.1. MEA Acute Respiratory Disease Diagnostics Market, 2021 - 2033 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. South Africa Acute Respiratory Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 7.6.2.2. Key Country Dynamics
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Reimbursement Scenario
      • 7.6.2.5. Competitive Scenario
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Saudi Arabia Acute Respiratory Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 7.6.3.2. Key Country Dynamics
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Reimbursement Scenario
      • 7.6.3.5. Competitive Scenario
    • 7.6.4. UAE
      • 7.6.4.1. UAE Acute Respiratory Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 7.6.4.2. Key Country Dynamics
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. Reimbursement Scenario
      • 7.6.4.5. Competitive Scenario
    • 7.6.5. Kuwait
      • 7.6.5.1. Kuwait Acute Respiratory Disease Diagnostics Market, 2021 - 2033 (USD Million)
      • 7.6.5.2. Key Country Dynamics
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Reimbursement Scenario
      • 7.6.5.5. Competitive Scenario

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
    • 8.2.1. New Product Launch
    • 8.2.2. Partnerships
    • 8.2.3. Acquisition
    • 8.2.4. Collaboration
    • 8.2.5. Funding
  • 8.3. Key Company Market Share Analysis, 2024
  • 8.4. Company Heat Map Analysis
  • 8.5. Company Profiles
    • 8.5.1. F. Hoffmann La-Roche
      • 8.5.1.1. Overview
      • 8.5.1.2. Financial Performance
      • 8.5.1.3. Product Benchmarking
      • 8.5.1.4. Strategic Initiatives
    • 8.5.2. Abbott Laboratories
      • 8.5.2.1. Overview
      • 8.5.2.2. Financial Performance
      • 8.5.2.3. Product Benchmarking
      • 8.5.2.4. Strategic Initiatives
    • 8.5.3. Quidel Corporation
      • 8.5.3.1. Overview
      • 8.5.3.2. Financial Performance
      • 8.5.3.3. Product Benchmarking
      • 8.5.3.4. Strategic Initiatives
    • 8.5.4. Becton, Dickinson and Company (BD)
      • 8.5.4.1. Overview
      • 8.5.4.2. Financial Performance
      • 8.5.4.3. Product Benchmarking
      • 8.5.4.4. Strategic Initiatives
    • 8.5.5. Thermo Fisher Scientific, Inc.
      • 8.5.5.1. Overview
      • 8.5.5.2. Financial Performance
      • 8.5.5.3. Product Benchmarking
      • 8.5.5.4. Strategic Initiatives
    • 8.5.6. Siemens Healthineers
      • 8.5.6.1. Overview
      • 8.5.6.2. Financial Performance
      • 8.5.6.3. Product Benchmarking
      • 8.5.6.4. Strategic Initiatives
    • 8.5.7. Bio-Rad Laboratories
      • 8.5.7.1. Overview
      • 8.5.7.2. Financial Performance
      • 8.5.7.3. Product Benchmarking
      • 8.5.7.4. Strategic Initiatives
    • 8.5.8. Luminex Corporation
      • 8.5.8.1. Overview
      • 8.5.8.2. Financial Performance
      • 8.5.8.3. Product Benchmarking
      • 8.5.8.4. Strategic Initiatives
    • 8.5.9. BioMerieux
      • 8.5.9.1. Overview
      • 8.5.9.2. Financial Performance
      • 8.5.9.3. Product Benchmarking
      • 8.5.9.4. Strategic Initiatives
    • 8.5.10. Meridian Bioscience
      • 8.5.10.1. Overview
      • 8.5.10.2. Financial Performance
      • 8.5.10.3. Product Benchmarking
      • 8.5.10.4. Strategic Initiatives
    • 8.5.11. Fujirebio Diagnostics
      • 8.5.11.1. Overview
      • 8.5.11.2. Financial Performance
      • 8.5.11.3. Product Benchmarking
      • 8.5.11.4. Strategic Initiatives
    • 8.5.12. Cepheid
      • 8.5.12.1. Overview
      • 8.5.12.2. Financial Performance
      • 8.5.12.3. Product Benchmarking
      • 8.5.12.4. Strategic Initiatives
    • 8.5.13. Lumos Diagnostics
      • 8.5.13.1. Overview
      • 8.5.13.2. Financial Performance
      • 8.5.13.3. Product Benchmarking
      • 8.5.13.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviation
  • Table 3 Global Acute Respiratory Disease Diagnostics Market, By Region, 2021 - 2033 (USD Million)
  • Table 4 Global Acute Respiratory Disease Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 5 Global Acute Respiratory Disease Diagnostics Market, By Pathogen, 2021 - 2033 (USD Million)
  • Table 6 Global Acute Respiratory Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 7 North America Acute Respiratory Disease Diagnostics Market, By Country, 2021 - 2033 (USD Million)
  • Table 8 North America Acute Respiratory Disease Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 9 North America Acute Respiratory Disease Diagnostics Market, By Pathogen, 2021 - 2033 (USD Million)
  • Table 10 North America Acute Respiratory Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 11 U.S. Acute Respiratory Disease Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 12 U.S. Acute Respiratory Disease Diagnostics Market, By Pathogen, 2021 - 2033 (USD Million)
  • Table 13 U.S. Acute Respiratory Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 14 Canada Acute Respiratory Disease Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 15 Canada Acute Respiratory Disease Diagnostics Market, By Pathogen, 2021 - 2033 (USD Million)
  • Table 16 Canada Acute Respiratory Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 17 Mexico Acute Respiratory Disease Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 18 Mexico Acute Respiratory Disease Diagnostics Market, By Pathogen, 2021 - 2033 (USD Million)
  • Table 19 Mexico Acute Respiratory Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 20 Europe Acute Respiratory Disease Diagnostics Market, By Country, 2021 - 2033 (USD Million)
  • Table 21 Europe Acute Respiratory Disease Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 22 Europe Acute Respiratory Disease Diagnostics Market, By Pathogen, 2021 - 2033 (USD Million)
  • Table 23 Europe Acute Respiratory Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 24 UK Acute Respiratory Disease Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 25 UK Acute Respiratory Disease Diagnostics Market, By Pathogen, 2021 - 2033 (USD Million)
  • Table 26 UK Acute Respiratory Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 27 Germany Acute Respiratory Disease Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 28 Germany Acute Respiratory Disease Diagnostics Market, By Pathogen, 2021 - 2033 (USD Million)
  • Table 29 Germany Acute Respiratory Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 30 France Acute Respiratory Disease Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 31 France Acute Respiratory Disease Diagnostics Market, By Pathogen, 2021 - 2033 (USD Million)
  • Table 32 France Acute Respiratory Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 33 Italy Acute Respiratory Disease Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 34 Italy Acute Respiratory Disease Diagnostics Market, By Pathogen, 2021 - 2033 (USD Million)
  • Table 35 Italy Acute Respiratory Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 36 Spain Acute Respiratory Disease Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 37 Spain Acute Respiratory Disease Diagnostics Market, By Pathogen, 2021 - 2033 (USD Million)
  • Table 38 Spain Acute Respiratory Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 39 Denmark Acute Respiratory Disease Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 40 Denmark Acute Respiratory Disease Diagnostics Market, By Pathogen, 2021 - 2033 (USD Million)
  • Table 41 Denmark Acute Respiratory Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 42 Sweden Acute Respiratory Disease Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 43 Sweden Acute Respiratory Disease Diagnostics Market, By Pathogen, 2021 - 2033 (USD Million)
  • Table 44 Sweden Acute Respiratory Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 45 Norway Acute Respiratory Disease Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 46 Norway Acute Respiratory Disease Diagnostics Market, By Pathogen, 2021 - 2033 (USD Million)
  • Table 47 Norway Acute Respiratory Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 48 Asia Pacific Acute Respiratory Disease Diagnostics Market, By Country, 2021 - 2033 (USD Million)
  • Table 49 Asia Pacific Acute Respiratory Disease Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 50 Asia Pacific Acute Respiratory Disease Diagnostics Market, By Pathogen, 2021 - 2033 (USD Million)
  • Table 51 Asia Pacific Acute Respiratory Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 52 Japan Acute Respiratory Disease Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 53 Japan Acute Respiratory Disease Diagnostics Market, By Pathogen, 2021 - 2033 (USD Million)
  • Table 54 Japan Acute Respiratory Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 55 China Acute Respiratory Disease Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 56 China Acute Respiratory Disease Diagnostics Market, By Pathogen, 2021 - 2033 (USD Million)
  • Table 57 China Acute Respiratory Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 58 India Acute Respiratory Disease Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 59 India Acute Respiratory Disease Diagnostics Market, By Pathogen, 2021 - 2033 (USD Million)
  • Table 60 India Acute Respiratory Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 61 Australia Acute Respiratory Disease Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 62 Australia Acute Respiratory Disease Diagnostics Market, By Pathogen, 2021 - 2033 (USD Million)
  • Table 63 Australia Acute Respiratory Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 64 South Korea Acute Respiratory Disease Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 65 South Korea Acute Respiratory Disease Diagnostics Market, By Pathogen, 2021 - 2033 (USD Million)
  • Table 66 South Korea Acute Respiratory Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 67 Thailand Acute Respiratory Disease Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 68 Thailand Acute Respiratory Disease Diagnostics Market, By Pathogen, 2021 - 2033 (USD Million)
  • Table 69 Thailand Acute Respiratory Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 70 Latin America Acute Respiratory Disease Diagnostics Market, By Country, 2021 - 2033 (USD Million)
  • Table 71 Latin America Acute Respiratory Disease Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 72 Latin America Acute Respiratory Disease Diagnostics Market, By Pathogen, 2021 - 2033 (USD Million)
  • Table 73 Latin America Acute Respiratory Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 74 Brazil Acute Respiratory Disease Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 75 Brazil Acute Respiratory Disease Diagnostics Market, By Pathogen, 2021 - 2033 (USD Million)
  • Table 76 Brazil Acute Respiratory Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 77 Argentina Acute Respiratory Disease Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 78 Argentina Acute Respiratory Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 79 MEA Acute Respiratory Disease Diagnostics Market, By Country, 2021 - 2033 (USD Million)
  • Table 80 MEA Acute Respiratory Disease Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 81 MEA Acute Respiratory Disease Diagnostics Market, By Pathogen, 2021 - 2033 (USD Million)
  • Table 82 MEA Acute Respiratory Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 83 South Africa Acute Respiratory Disease Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 84 South Africa Acute Respiratory Disease Diagnostics Market, By Pathogen, 2021 - 2033 (USD Million)
  • Table 85 South Africa Acute Respiratory Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 86 Saudi Arabia Acute Respiratory Disease Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 87 Saudi Arabia Acute Respiratory Disease Diagnostics Market, By Pathogen, 2021 - 2033 (USD Million)
  • Table 88 Saudi Arabia Acute Respiratory Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 89 UAE Acute Respiratory Disease Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 90 UAE Acute Respiratory Disease Diagnostics Market, By Pathogen, 2021 - 2033 (USD Million)
  • Table 91 UAE Acute Respiratory Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 92 Kuwait Acute Respiratory Disease Diagnostics Market, By Test, 2021 - 2033 (USD Million)
  • Table 93 Kuwait Acute Respiratory Disease Diagnostics Market, By Pathogen, 2021 - 2033 (USD Million)
  • Table 94 Kuwait Acute Respiratory Disease Diagnostics Market, By End Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Acute Respiratory Disease Diagnostics Market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment.
  • Fig. 8 Market formulation & validation
  • Fig. 9 Acute Respiratory Disease Diagnostics Market snapshot
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook.
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Acute Respiratory Disease Diagnostics Market driver impact
  • Fig. 14 Acute Respiratory Disease Diagnostics Market restraint impact
  • Fig. 15 SWOT analysis, by factor (political & legal, economic, and technological)
  • Fig. 16 Industry Analysis - Porter's
  • Fig. 17 Strategy mapping
  • Fig. 18 Acute Respiratory Disease Diagnostics Market: Test outlook and key takeaways
  • Fig. 19 Acute Respiratory Disease Diagnostics Market: Test movement analysis & market share 2024 & 2033
  • Fig. 20 Molecular Diagnostics Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 21 PCR Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 22 INAAT Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 23 Antigen-based Rapid Tests Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 24 Serological Tests (IgM/IgG) Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 25 Syndromic Respiratory Panels Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 26 Other Emerging Technologies (CRISPR-based, Nanopore Sequencing, AI-driven Imaging) Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 27 Acute Respiratory Disease Diagnostics Market: Pathogen outlook and key takeaways
  • Fig. 28 Acute Respiratory Disease Diagnostics Market: Pathogen movement analysis & market share 2024 & 2033
  • Fig. 29 Viral Infections Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 30 Influenza A & B Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 31 Respiratory Syncytial Virus (RSV) Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 32 SARS-CoV-2 Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 33 Others Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 34 Bacterial Infections Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 35 Streptococcus Pneumoniae Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 36 Haemophilus influenzae Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 37 Mycoplasma pneumoniae Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 38 Bordetella pertussis Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 39 Others Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 40 Acute Respiratory Disease Diagnostics Market: End Use outlook and key takeaways
  • Fig. 41 Acute Respiratory Disease Diagnostics Market: End Use movement analysis & market share 2024 & 2033
  • Fig. 42 Hospitals & Clinics Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 43 Diagnostic and Reference Labs Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 44 Home Testing Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 45 Others (Public health, surveillance labs) Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 46 Regional marketplace: Key takeaways
  • Fig. 47 Global Acute Respiratory Disease Diagnostics Market: Regional movement analysis
  • Fig. 48 U.S. Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 49 Canada Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 50 Mexico Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 51 Europe Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 52 UK Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 53 Germany Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 54 France Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 55 Italy Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 56 Spain Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 57 Denmark Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 58 Sweden Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 59 Norway Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 60 Asia Pacific Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 61 Japan Market Estimates and Forecast, 2021 - 2033(USD Million)
  • Fig. 62 China Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 63 India Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 64 South Korea Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 65 Australia Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 66 Thailand Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 67 Latin America Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 68 Brazil Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 69 Argentina Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 70 MEA Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 71 South Africa Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 72 Saudi Arabia Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 73 UAE Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 74 Kuwait Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 75 Strategy framework